-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Share
Listen to the news

Gainers

  • Aditxt (NASDAQ:ADTX) stock moved upwards by 247.7% to $0.02 during Thursday's pre-market session.
  • CervoMed (NASDAQ:CRVO) shares increased by 25.72% to $4.79. The market value of their outstanding shares is at $35.2 million.
  • QTREX Quantum (NASDAQ:QTEX) stock rose 22.63% to $2.33. The market value of their outstanding shares is at $99.9 million.
  • Butterfly Network (NYSE:BFLY) stock increased by 16.85% to $6.67. The market value of their outstanding shares is at $1.4 billion.
  • Spero Therapeutics (NASDAQ:SPRO) shares rose 16.11% to $2.45. The market value of their outstanding shares is at $122.1 million.
  • Agape ATP (NASDAQ:ATPC) shares rose 15.75% to $3.16. The market value of their outstanding shares is at $2.7 million.

Losers

  • Profusa (NASDAQ:PFSA) shares declined by 31.0% to $0.18 during Thursday's pre-market session. The company's market cap stands at $1.1 million.
  • NewGenIvf Group (NASDAQ:NIVF) stock decreased by 22.33% to $0.62. The market value of their outstanding shares is at $2.2 million.
  • Elicio Therapeutics (NASDAQ:ELTX) shares fell 20.73% to $3.73. The market value of their outstanding shares is at $89.8 million.
  • Ernexa Therapeutics (NASDAQ:ERNA) shares declined by 14.95% to $5.01. The market value of their outstanding shares is at $6.8 million.
  • NovoCure (NASDAQ:NVCR) stock fell 14.57% to $15.25. The company's market cap stands at $2.0 billion.
  • Lunai Bioworks (NASDAQ:LNAI) stock fell 14.1% to $3.44. The market value of their outstanding shares is at $18.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending